Case Study:

Global Partnership of a Pre-Clinical Asset on Behalf of a Pharmaceutical Company

Learn how a U.S. company with a CNS (central nervous system) asset and pre-clinical data secured the cash infusion they needed to expand globally and continue development - all while protecting the U.S. rights for their product.